The ART BMC System by Celling Biosciences Is Revolutionizing the Practice of Cell Therapy

Austin, TX, May 7, 2016 (Newswire.com) - The ART BMC bone marrow concentration systems are  best-in-class devices for the point-of-care concentration of bone marrow aspirate (BMA).  The systems recover the greatest percentage of nucleated and progenitor cells by allowing selection of the cell concentrate from user-defined portions of the centrifuged stack.  

"I have physicians that ask me all the time which biologic product we think is the best for cell therapy in the market and we most definitely recommend Celling Biosciences' products!" Ginger Lichlyter with MedRebels.

Ginger Lichlyer, Director of Marketing for MedRebels

The new system by Celling Biosciences concentrates autologous bone marrow aspirate effectively and efficiently at the point-of-care in 15 minutes.  Essential cell, growth factors and proteins are found within the stratified stack of the bone marrow concentrate.  The dual capture system of the ART BMC Plus allows users to selectively deconstruct the stack in order to optimize the composition of the final preparation (e.g. BMC, fibrinogen, etc).

Source: Celling Biosciences